Sharda Cropchem Limited has informed the Exchange about Investor Presentation
Shard" Cropchenl Limited
Tel. • +91 22667B2BOO FAX . +91 2266782828/66782808 E-mail . office@shardaintlcom Regd . Office : Prime Business Park , Dashrathlal Joshi Road, Vile Parle rN),
Mumbai - 400056, India.
www.shardacropchem .com
ISO 9ao1 : 2015 Reg. No: 702949
CIN: LS1909MH2004PLC145007
21 st October, 2022
To ,
National Stock Exchange of Li mited Exchange Plaza , 5th Floor, Plot No . C/1 , G-Block, Band ra Kurla Complex , Sandra (E) , Mumbai - 400051
India BSE Limited
Phiroze Jeejeebhoi Tower, Dalal Street, Mumbai - 400001
Trading Symbol: SHARDACROP
Scrip Code: 538666
Subject: Investors I Analyst' s Presentation for the quarter & half year ended 30th September, 2022:
Dear Sir/Madam ,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015 (Listing Regulations), we are enclosing herewith the presentation to be made to the Investors/Analysts on the Financial Results of the Company for the quarter & half year ended 30 th September, 2022.
The presentation wwwshardacropchem .com in accordance with Regulation 46 of the Listing Regulations.
is also being uploaded on
the website of
the Company
We request you to take the same on record.
Yours Sincerely ,
Jetkin Gudhka Company Secretary & Compliance Officer
Ene!.: As above
Investor Presentation October 2022
Safe Harbor
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sharda Cropchem Limited (the “Company”), have been prepared solely for
information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection
with any contract or binding commitment what so ever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed
information about the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty,
express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This
Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this
Presentation is expressly excluded
Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively
forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions
that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets,
the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion,
technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as
other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation.
The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties
included in this Presentation are not adopted by the Company and the Company is not responsible for such third party statements and projections.
2
About Sharda Cropchem Limited
“We are a fast-growing global agrochemicals company with a peer position in the generic crop protection chemicals industry. Our vast and growing library of dossiers and IPRs provide us solid foundations for growth in the global marketplace, especially in Advanced Markets such as Europe, North America and Latin America. It equips us with the ability to operate in a diversified range of formulations and generic active ingredients space globally”
Agrochemical Focused Company
Intellectual Property (IP) driven company engaged in marketing and distribution of wide range formulations and generic active ingredients
Asset Light Business Model
Efficiently channelizing time and resources for strengthening core competency of identifying generic molecules and registration opportunities which offer scalable growth with limited capital requirements
Large Pipeline of Registrations*
Procured 2,753 registrations. Additionally, it has filed 1,118 applications for registrations globally pending at different stages
Diversified Sourcing Arrangements
Enduring relationship with multiple manufacturers and formulators enables to source and supply formulations or generic active ingredients at competitive prices
Consistently Increasing Global Presence
With diversified range of product portfolio, Company has grown by expanding business operations in 80+ countries, across Europe, NAFTA, Latin America and ROW
Widespread Distribution Network
Presence in the entire agrochemical value chain with 500 third party distributors and 400+ sales force serving the Company’s esteemed clientele in 80+ countries
Company’s apt domain knowledge and experience gives substantial competitive advantage for expanding business in existing markets and new geographies
As on 30th September 2022
5
Asset Light Business Model
Overall Agrochemical Value Chain
Sharda’s Operating Area
√
√
√
√
Basic & Applied Research
Identification
Registration
Active Ingredient Manufacturing
Formulation & Packaging
Marketing & Distribution
SHARDA CROPCHEM’s ASSET LIGHT BUSINESS MODEL
Focus on identification of generic molecules, preparing dossiers, seeking registrations, marketing & distributing formulations through third party distributors and/or own sales force
Manufacturing of AIs and formulations is outsourced
Highly flexible operating model resulting in • Overall cost competitiveness • Efficient management of fluctuating market
demand across various geographies
• Offering wide range of formulations and AIs
Acts as a key differentiator from an innovator company, allowing the Company to save its capital, time and resources on R&D
6
Increasing Global Presence having a Widespread Distribution
Presence 80+ countries
across Europe, NAFTA, LATAM & RoW
Sales Force 400+
Distributors 500+
CAPEX incurred in H1 FY23* Rs. 230 Cr.
Over the years, we’ve built a strong brand franchise within our global markets; we are benefiting through the economies of scale in our portfolio and leveraging value of our supply chain to deliver value to our customers across geographies
Company has gained a great deal from globalization, including new customers and diverse geocentric revenue streams. Over the years, we have mastered flexibility and adopted innovative ways to grow our business overseas
In addition to newer markets, the wide global presence has allowed us to find new, specialised sales and local marketing talent.
Successfully adopted a factory-to- farmer approach to become a one- stop solution provider to our global customers
Strengthening and widening the sales force in Europe, USA, Canada, Mexico, Colombia, South Africa, India, and rest of the world, in addition to third party distributors with a goal to enhance its presence in the agrochemical value chain
It enables the Company to penetrate its formulations and generic active ingredients in various countries backed by the third-party distributors and presence of its own sales force
* Plus related revenue expenditure on registrations
7
The Sharda Advantage
THE SHARDA ADVANTAGE
Global Reach
Wide Product Range
Healthy relationships with suppliers
Quality with Affordability
Faster Sales Service
One Stop Solution Provider for Crop Care Products
8
Way Forward
Forward Integration - Build Sales Force
Expand & Strengthen Distribution Presence
➢ Leverage market presence and execution capabilities
➢ Expand geographical reach using existing library of
➢ Adopt the factory to farmer approach and be a one stop
solution provider
➢ Strategy on ground in different regions of NAFTA, Europe, LATAM and other key markets in ROW
dossiers
➢ Two-fold strategy of further penetrating existing markets
and entering new markets
Continual Investment in Product Registrations
Focus on Operational Efficiencies
➢ Continue to identify generic molecules going off patent
➢ Accelerated focus on revenue generating investments
➢ Investing in preparing dossiers and seeking registrations
➢ Margin improvements
in own name
➢ Better cost management and eliminate NVAs
9
Industry Outlook and Growth Drivers
Global crop protection chemicals market value (In Billion USD) – CAGR of 3.5%
59.7
8.1
42.0
62.8
77.0
43.7
53.0
5.3
2020
3.9
0.5
8.4
5.9
4.3
0.6
2025e
10.2
7.7
5.4
0.8
2030e
Herbicide
Fungicide
Insecticide
Nematicide
Molluscicide
INDUSTRY DRIVERS
1
2
3
A growing population: the global population is set to increase by 1.2 billion by 2030 and 2 billion by 2050, while the middle class will more than double to 4.9 billion by 2030
A growing middle class fuels demand for increased food and protein production, which in turn drives demand for grain to support growth
Fewer arable acres per capita means that products need to continue to maximise farmer yields; arable land is expected to decrease from half an acre per person today to less than one- third of an acre per person by 2050
Primary Research, Secondary Research, Magna Information Centre
10
Experienced Management
Mr. Ramprakash V. Bubna Chairman & Managing Director
Mr. Ashish Bubna Whole Time Director
Mr. Manish Bubna Whole Time Director
Mr. Ashok Vashisht Chief Financial Officer
•
•
•
Holds a Bachelor’s Degree of Technology in Chemical Engineering from IIT, Bombay
He has over 53 years of experience in chemicals, agrochemicals and related businesses
He is responsible for the Company’s overall business operations and strategy
•
•
•
•
Holds a Bachelor’s Degree in Commerce from the University of Mumbai
Over 30 years of experience in marketing of chemicals, agrochemicals and related businesses.
Instrumental in strategizing early investment in product registrations and building the library of product dossiers.
Responsible for marketing, procurement, registrations and logistics functions of the agrochemical business.
•
•
•
•
Holds a Bachelor’s Degree in Chemical Engineering from the Department of Chemical Technology, Bombay University.
Over 28 years of experience in chemicals, agrochemicals and related businesses
Spearheaded the Company’s foray into the conveyor belt and general chemicals business
Also oversees the information technology, logistics and documentation functions of the Company
•
•
He is Fellow member of Chartered Institute of Management Accountants UK & accredited CGMA, Fellow member of CPA Australia, Fellow member of The Institute of Cost Accountants of India and Associate member of The ICSI. He has also done DipIFR from ACCA UK and qualified Independent Director from IICA
25+ years of rich professional corporate experience in global and Indian MNCs in the field of Strategy, M&A, Financial Management, Direct & Indirect Taxation, Strategic Cost Management, Project Management, Statutory Audits & Internal Audits, Governance & Risk Management
11
Q2 FY23 Financial Highlights
Q2 FY23: Segment Wise Highlights
Agrochemical Segment
Non Agrochemical Segment
TOTAL REVENUES
78%
503
80%
576
22%
140
20%
146
% of Revenue
100%
100%
643
722
Cr.
Q2FY22
Q2FY23
Q2FY22
Q2FY23
Q2FY22
Q2FY23
+14%
+4%
+12%
On Consolidated Basis
13
Q2 FY23: Product Wise Highlights (Agrochemical Segment)
Herbicides
Insecticides
Fungicides
Cr.
TOTAL REVENUES (Agrochemical Segment)
52%
57%
32%
22%
16%
21%
% of Revenue
100%
100%
327
159
124
261
125
83
576
503
Q2FY22
Q2FY23
Q2FY22
Q2FY23
Q2FY22
Q2FY23
Q2FY22
Q2FY23
+25%
-22%
+50%
14%
On Consolidated Basis
14
Q2 FY23: Region Wise Breakup (Agrochemical Segment)
Europe
NAFTA Region
43%
216
+11%
41%
238
36%
179
+28%
40%
230
Q2FY22
Q2FY23
Q2FY22
Q2FY23
LATAM Region
14%
71
-10%
11%
64
RoW
+18%
8%
44
7%
37
Q2FY22
Q2FY23
Q2FY22
Q2FY23
% of Revenue
Cr.
TOTAL REVENUES (Agrochemical Segment)
576
503
Q2FY22
Q2FY23
+14%
On Consolidated Basis
15
Q2 FY23: Region Wise Breakup (Non Agrochemical Segment)
Europe
NAFTA Region
30%
41
-22%
22%
32
50%
70
+19%
57%
83
Q2FY22
Q2FY23
Q2FY22
Q2FY23
LATAM Region
5%
8
+26%
7%
10
RoW
+1%
14%
21
15%
21
Q2FY22
Q2FY23
Q2FY22
Q2FY23
% of Revenue
Cr.
TOTAL REVENUES (Non - Agrochemical Segment)
140
146
Q2FY22
Q2FY23
+4%
On Consolidated Basis
16
Q2 FY23: Financial Highlights
Revenues & GP Margin
EBITDA & EBITDA Margin*
Cr.
28.0%
643
27.3%
722
Revenue growth led by better product mix & price realization
Gross Margins have been impacted by weakening of €/$ leading to increased input cost
+12%
16.1%
14.8%
104
107
Q2FY22
Q2FY23
Q2FY22
Q2FY23
EBITDA and Margin impacted due to lower GP Margins, general inflation and strengthening of global workforce to support future growth
+3%
Profit After Tax & PAT Margin
Profit After Tax & PAT Margin (Excluding Forex Impact)
5.0%
1.7%
32
12
- 62%
PAT was impacted by increased forex losses of Rs. Rs. 38.7 crores in Q2 FY23
7.0%
45
7.0%
51
Q2FY22
Q2FY23
Q2FY22
Q2FY23
+12%
Excluding Forex Loss, PAT has grown by 12% due to revenue growth , product mix & increased efficiencies
* Excluding 1. Other expenses of Rs 1.79 Crs. towards loss on fair valuation of investments during quarter ended September 30, 2022 as against gain of Rs.2.25 Crs. for corresponding quarter ended September 30, 2021 which has been included under Other Income
2. EBITDA is excluding IA & IAUD write-off (Rs. 1.5 cr. in Q2 FY23; Rs. 0.9 cr. in Q2 FY22 ; (IA & IAUD – Intangible Assets & Intangible Assets Under Development)
On Consolidated Basis
17
Impact of weakened Euro to the Dollar in the last six months
USD / Euro Price Chart
1.11
1.1500
1.1000
1.0500
1.0000
0.9500
Unprecedented depreciation of Euro to the USD
- 12%
0.98
01-04-2022
21-04-2022
11-05-2022
31-05-2022
20-06-2022
10-07-2022
30-07-2022
19-08-2022
08-09-2022
28-09-2022
Euro Dollar Exchange Rate
Major currencies have depreciated to the USD in the last six months due to the ongoing war between Russia & Ukraine
Over 45% of H1 FY23 Sales from Agrochemical business have been to the Europe whereas majority of the Company’s Raw Material is imported from China and payments are done in US Dollar
This has impacted the Company’s Gross Margin and overall profitability as the Euro had considerably depreciated against the dollar
MEASURES TAKEN BY COMPANY
•
Increased sales focus on NAFTA region
• Sourcing in Euro currency
• Optimal Hedging of currencies
• Seeking Price increase to minimize this forex impact
18
H1 FY23 Financial Highlights
H1 FY23 Segment Wise Highlights
Cr.
Agrochemical Segment
Non Agrochemical Segment
TOTAL REVENUES
82%
1,037
77%
1,190
23%
356
18%
228
% of Revenue
100%
100%
1,546
1,265
H1FY22
H1FY23
H1FY22
H1FY23
H1FY22
H1FY23
+15%
+56%
+22%
On Consolidated Basis
20
H1 FY23: Product Wise Highlights (Agrochemical Segment)
Herbicides
Insecticides
Fungicides
Cr.
TOTAL REVENUES (Agrochemical Segment)
50%
57%
28%
19%
22%
24%
% of Revenue
100%
100%
681
295
279
515
230
227
1,190
1,037
H1FY22
H1FY23
H1FY22
H1FY23
H1FY22
H1FY23
H1FY22
H1FY23
+32%
-22%
+24%
+15%
On Consolidated Basis
21
H1 FY23: Region Wise Breakup (Agrochemical Segment)
Europe
NAFTA Region
45%
466
+18%
46%
551
34%
355
+19%
36%
422
H1FY22
H1FY23
H1FY22
H1FY23
LATAM Region
15%
155
-6%
12%
146
RoW
+18%
6%
71
6%
61
H1FY22
H1FY23
H1FY22
H1FY23
% of Revenue
Cr.
TOTAL REVENUES (Agrochemical Segment)
1,190
1,037
H1FY22
H1FY23
+15%
On Consolidated Basis
22
H1 FY23: Region Wise Breakup (Non Agrochemical Segment)
Europe
NAFTA Region
29%
65
+39%
26%
91
+82%
56%
197
47%
109
H1FY22
H1FY23
H1FY22
H1FY23
LATAM Region
+81%
6%
23
6%
13
RoW
+7%
12%
45
18%
41
H1FY22
H1FY23
H1FY22
H1FY23
% of Revenue
Cr.
TOTAL REVENUES (Non - Agrochemical Segment)
356
228
H1FY22
H1FY23
+56%
On Consolidated Basis
23
H1 FY23: Financial Highlights
Revenues & GP Margin
EBITDA & EBITDA Margin*
Cr.
28.6%
1,265
26.3%
1,546
Revenue growth led by better product mix & price realization
Gross Margins have been impacted by weakening of €/$ leading to increased input cost
+22%
16.6%
210
14.1%
218
H1FY22
H1FY23
H1FY22
H1FY23
EBITDA and Margin impacted due to lower GP Margins , general inflation and strengthening of global workforce to support future growth
+4%
Profit After Tax & PAT Margin
Profit After Tax & PAT Margin (Excluding Forex Impact)
5.5%
70
2.2%
35
- 50%
PAT was impacted by increased forex losses of Rs. Rs. 81.9 crores in H1 FY23
5.7%
72
7.5%
117
+62%
Excluding Forex Loss, PAT has grown by 62% due to revenue growth, product mix & increased efficiencies
H1FY22
H1FY23
H1FY22
H1FY23
* Excluding 1. Other expenses of Rs 13.94 Crs. towards loss on fair valuation of investments during half year ended September 30, 2022 as against gain of Rs.3.52 Crs. for corresponding half year ended September 30, 2021 which has been included under Other Income
2. EBITDA is excluding IA & IAUD write-off (Rs. 4.3 cr. in H1 FY23; Rs. 4.4 cr. in H1 FY22 ; (IA & IAUD – Intangible Assets & Intangible Assets Under Development)
On Consolidated Basis
24
Strong Balance Sheet
Working Capital (in Days)
86 days
91 days
92
67
73
74
86
70
RoCE
+550 bps
RoE
+470 bps
20.2%
25.7%
15.2%
19.8%
Mar-21
Mar-22
Mar-21
Mar-22
Total Equity
Total Debt
Cash & Cash Equivalents
Sep-21
Sep-22
Inventory Days
Recievable Days
Creditor Days
Rs. 1,930 crores
Rs. 17 crores
Rs. 283 crores
Rs. 1,912 crores as on Mar’22
Rs. 38 crores as on Mar’22
Rs. 300 crores as on Mar’22
ROE: PAT/Avg. Equity, ROCE: EBIT/Avg. Capital Employed [(Capital Employed = Equity + Total Debt)]
On Consolidated Basis
25
Annexure
Q2 & H1 FY23 Financial Highlights
Particulars
Revenue from Operations
COGS
Gross Profit
Gross Margin %
Employee Expenses
Other Expenses
EBITDA*
EBITDA Margin %
Forex (Gain)/Loss
Depreciation
Other Income
EBIT
EBIT Margin %
Finance Cost
PBT
Tax Expense
PAT
PAT Margin %
Earnings Per Share (EPS) In Rs.
PAT (Excluding Forex Impact)
PAT Margin % (Excluding Forex Impact)
Q2 FY23
Q2 FY22
721.5
524.4
197.1
27.3%
8.6
84.9
107.0
14.8%
38.6
60.4
10.2
14.9
2.1%
0.4
14.5
2.5
12.1
1.7%
1.34
50.7
7.0%
642.8
462.9
179.8
28.0%
10.5
66.4
103.8
16.1%
13.2
60.6
12.9
42.0
6.5%
0.4
41.5
9.5
32.0
5.0%
3.55
45.2
7.0%
Y-o-Y
12%
3%
-62%
12%
H1 FY23
1,546.0
1,139.5
406.5
26.3%
17.0
189.7
218.1
14.1%
81.9
115.1
30.5
33.3
2.2%
1.1
32.2
-2.5
34.7
2.2%
3.85
116.6
7.5%
Cr.
H1 FY22
1,265.5
Y-o-Y
22%
903.1
362.4
28.6%
20.6
135.8
210.4
16.6%
1.7
114.6
19.3
109.0
8.6%
1.0
108.0
37.9
70.1
5.5%
7.77
71.8
5.7%
4%
-50%
62%
* Excluding Other expenses of Rs 1.79 Crs. towards loss on fair valuation of investments during quarter ended September 30, 2022 as against gain of Rs.2.25 Crs. for corresponding quarter ended September 30, 2021 which has been included under Other Income. Excluding Other expenses of Rs 13.94 Crs. towards loss on fair valuation of investments during half year ended September 30, 2022 as against gain of Rs.3.52 Crs. for corresponding half year ended September 30, 2021 which has been included under Other Income
* EBITDA is excluding IA & IAUD write-off (Rs. 1.5 cr. in Q2 FY23; Rs. 0.9 cr. in Q2 FY22 ; Rs. 4.3 cr. in H1 FY23; Rs. 4.4 cr. in H1 FY22
On Consolidated Basis
27
Balance Sheet - Consolidated
EQUITY & LIABILITIES Equity Equity share capital Other equity Equity attributable to equity holders of the Company Non-controlling interests Total Equity Non-current liabilities Financial liabilities Lease liabilities Trade payables
total outstanding dues of micro enterprises and small enterprises other than micro enterprises and small enterprises
Other financial liabilities Provisions Deferred tax liabilities (net) Total non-current liabilities Current liabilities Financial liabilities Borrowings Lease liabilities Trade payables
total outstanding dues of micro enterprises and small enterprises other than micro enterprises and small enterprises
Other financial liabilities Other current liabilities Provisions Income Tax Provisions Total current liabilities Total Equity & Liabilities
Sept-22
Mar-22
ASSETS
Sept-22
Mar-22
90.2 1,840.4 1,930.6 0.3 1,930.9
1.3
1.7 2.4 123.3 128.7
17.0 4.8
4.7 719.3 414.8 39.1 90.1 3.5 1,293.3 3,352.9
90.2 1,822.2 1,912.4 0.3 1,912.7
3.5
0.0 2.4 1.6 2.3 128.9 138.7
38.0 5.1
8.8 1,168.8 324.8 55.4 86.7 4.2 1,691.8 3,743.2
Non-current assets
Property, plant and equipment
Goodwill
Intangible assets
Intangible assets under development
Financial assets
Other Financial Assets
Deferred Tax Assets
Income tax assets (net)
Total non-current assets
Current assets
Inventories
Financial assets
Investments
Trade receivables
Cash and cash equivalents
Bank balance other than cash and cash equivalents
Loans
Other financial assets
Other current assets
Total current assets
Total Assets
11.1
0.0
700.1
199.1
0.0
13.5
4.5
83.1
14.4
0.0
577.4
212.2
0.0
11.2
4.9
71.6
1,011.4
891.7
965.5
892.8
75.0
999.9
97.9
110.2
0.0
24.9
68.1
2,341.5
3,352.9
134.4
1,540.0
56.7
109.3
0.5
48.9
68.9
2,851.5
3,743.2
28
Key Financial Performance Indices
Revenue
EBITDA & EBITDA Margin*
Profit After Tax & PAT Margin
Cr.
1,707
1,998
2,003
2,396
3,580
20.7%
18.5%
17.6%
19.0%
20.4%
11.2%
8.8%
8.2%
9.6%
9.8%
353
369
352
455
191
176
165
229
729
349
FY18
FY19
FY20
FY21
FY22
FY18
FY19
FY20
FY21
FY22
FY18
FY19
FY20
FY21
FY22
RoCE
RoE
Net Cash & Cash Equivalents^
25.8%
25.7%
18.2%
19.8%
336
18.8%
20.2%
13.9%
14.6%
12.3%
15.2%
269
276
262
FY18
FY19
FY20
FY21
FY22
FY18
FY19
FY20
FY21
FY22
-47 FY18
FY19
FY20
FY21
FY22
* EBITDA is excluding IA & IAUD write-off
^ Total Cash & Cash Equivalents - Debt
On Consolidated Basis
29
Historical Profit & Loss
Particulars
Revenue from Operations
COGS
Gross Profit
Gross Margin %
Employee Expenses
Other Expenses
EBITDA*
EBITDA Margin %
Forex (Gain)/Loss
Depreciation
Other Income
EBIT
EBIT Margin %
Finance Cost
PBT
Tax Expense
PAT
PAT Margin %
Earnings Per Share (EPS) In Rs.
* EBITDA is excluding IA & IAUD write-off
FY22
3,579.8
2,499.8
1,080.0
30.2%
44.2
336.4
728.6
20.4%
16.5
245.3
28.9
466.5
13.0%
2.2
464.2
115.0
349.3
9.8%
38.71
FY21
2,395.6
1,636.0
759.7
31.7%
37.3
305.5
455.2
19.0%
-19.9
170.4
45.9
312.2
13.0%
2.8
309.5
80.2
229.2
9.6%
25.40
FY20
2,003.0
1,388.8
614.3
30.7%
34.9
282.4
351.7
17.6%
15.1
137.1
42.1
186.8
9.3%
1.9
184.9
20.2
164.7
8.2%
18.25
FY19
1,997.6
1,387.3
610.2
30.5%
33.5
250.1
368.8
18.5%
4.5
99.4
20.6
243.4
12.2%
8.4
235.0
58.7
176.3
8.8%
19.55
Cr.
FY18
1,706.6
1,143.7
562.8
33.0%
33.5
183.9
353.3
20.7%
-8.5
69.9
8.1
292.1
17.1%
4.9
287.2
96.4
190.8
11.2%
21.15
On Consolidated Basis
30
Balance Sheet – Equity & Liabilities
Equities & Liabilities Shareholder's Funds Equity and Share Capital Other Equity Non-controlling Interest Total Equity
Non-Current Liabilities Borrowings Trade Payables Lease Liabilities Other Financial Liabilities Provisions Deferred Tax Liabilities (net) Total Non-Current Liabilities
Current Liabilities Borrowings Lease Liabilities Trade Payables Other Financial Liabilities Other Current Liabilities Current Tax Liabilities Provisions Total Current Liabilities Total Equity & Liabilities
FY22
90.2 1,822.2 0.3 1,912.8
- 2.4 3.5 1.6 2.3 128.9 138.6
38.0 5.1 1,177.6 324.8 55.4 4.2 86.7 1,691.8 3,743.1
FY21
90.2 1,524.1 0.3 1,614.6
- 2.4 8.4 3.2 3.0 92.9 109.9
67.8 4.5 806.8 149.1 58.0 3.2 50.0 1,139.4 2,863.9
FY20
90.2 1,312.6 0.3 1,403.1
0.1 2.4 - 13.1 2.7 69.3 87.5
0.0 - 686.7 89.7 54.4 1.5 24.4 856.7 2,347.2
FY19
90.2 1,193.7 0.2 1,284.1
0.1 2.9 - 1.4 2.2 91.0 97.6
0.0 - 636.2 104.0 60.7 0.6 20.1 821.7 2,203.3
Cr.
FY18
90.2 1,044.6 0.2 1,135.0
0.1 3.0 - 0.3 2.1 83.1 88.6
169.6 - 633.8 106.2 56.1 24.0 12.9 1,002.6 2,226.2
On Consolidated Basis
31
Balance Sheet - Assets
ASSETS
Assets
Non-Current Assets
Property, Plant and Equipment
Goodwill
Other Intangible assets
Intangible assets under development
Deferred Tax Assets (net)
Non-Current Tax Assets
Other financial assets
Total Non-Current Assets
Current Assets
Inventories
Investments
Trade Receivables
Cash & Cash equivalents
Other Bank balances
Loans
Other Financial Assets
Other Current Assets
Total Current Assets
Total Assets
FY22
FY21
FY20
FY19
FY18
Cr.
14.4
0.0
577.4
212.2
4.9
71.6
11.2
891.7
892.8
134.4
1,540.0
56.7
109.3
0.5
48.9
68.9
2,851.5
3,743.1
20.9
0.4
523.1
131.0
6.0
73.6
9.4
764.5
525.5
83.0
1,162.6
85.6
175.0
-
28.1
39.6
2,099.3
2,863.9
27.8
0.4
388.1
161.4
3.9
72.5
11.6
665.7
382.2
115.5
988.4
77.8
75.7
-
11.3
29.6
13.5
0.4
357.8
219.8
5.5
49.2
8.9
655.2
364.9
211.9
811.4
50.6
73.0
-
11.9
24.3
10.7
0.4
215.2
359.9
40.0
29.3
7.3
662.9
530.4
22.1
891.9
61.3
39.3
-
0.0
18.3
1,681.5
2,347.2
1,548.2
2,203.3
1,563.3
2,226.2
On Consolidated Basis
32
CSR Activities
CSR initiatives taken up by the Company are in the areas of Promoting Education, Healthcare, Eradicating Hunger, Empowerment of Women, Animal Welfare, Promotion of Sports and Rural Development Projects
Promoting Education
Animal Welfare
Medical Aid & Relief
33
THANK YOU
Company: Sharda Cropchem Limited
Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd.
CIN: L67120MH1995PLC086696
CIN: U74140MH2010PTC204285
Mr. Ashok Vashisht - CFO cfo@shardaintl.com Tel: +91 22 6678 2800
Mr. Deven Dhruva / Mr. Karan Parekh deven.dhruva@sgapl.net / karan.parekh@sgapl.net Tel: +91 98333 73300 / +91 74983 98940